PUK Stock Analysis: Prudential | NYSE

Insurance - Life | NYSE, USA | Market Cap: 34.896m USD | 12M Return: 7% | US74435K2042 | Charts, Fundamentals & Technical Analysis

Life Insurance, Health Insurance, Asset Management, Wealth Protection
Total Rating 32
Safety 21
Buy Signal -0.75
Insurance - Life
Industry Rotation: -7.6
Market Cap: 34.9B
Avg Turnover: 26.3M
Risk 3d forecast
Volatility29.8%
VaR 5th Pctl5.39%
VaR vs Median9.68%
Reward TTM
Sharpe Ratio0.22
Rel. Str. IBD31.9
Rel. Str. Peer Group16.7
Character TTM
Beta0.714
Beta Downside0.713
Hurst Exponent0.474
Drawdowns 3y
Max DD37.13%
CAGR/Max DD0.24
CAGR/Mean DD0.70
EPS (Earnings per Share) EPS (Earnings per Share) of PUK over the last years for every Quarter: "2021-09": 0, "2021-12": 1.02, "2022-03": 0, "2022-06": 0.04, "2022-09": 0, "2022-12": 0.33, "2023-03": 0, "2023-06": 0, "2023-09": 0, "2023-12": 0, "2024-03": 0, "2024-06": 0, "2024-09": 0, "2024-12": 0.8, "2025-06": 0.49, "2025-12": null, "2026-06": null,
Qual. Beats: 0
Revenue Revenue of PUK over the last years for every Quarter: 2021-09: null, 2021-12: 10967.07957, 2022-03: null, 2022-06: 1911.65377, 2022-09: null, 2022-12: 4628.2959, 2023-03: null, 2023-06: 4267.08317, 2023-09: null, 2023-12: 4407.71217, 2024-03: null, 2024-06: 4212.44775, 2024-09: null, 2024-12: 3926.552, 2025-06: 12513.934, 2025-12: 15267.144, 2026-06: 14936.19096,
Rev. CAGR: 81.71%
Rev. Trend: 92.0%
Qual. Beats: 0

Warnings

Choppy
Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 11.6 years of data

Jan -1.4% 5
Feb -5.2% 9
Mar -0.7% 17
Apr +1.0% 15
May -3.8% 17
Jun -1.1% 17
Jul +1.6% 22
Aug -3.4% 28
Sep -1.1% 14
Oct -3.0% 39
Nov +1.2% 16
Dec +1.1% 39

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: PUK Prudential

Prudential plc is a life and health insurance and asset management provider focused on individuals in Asia and Africa. Its offerings span savings and investments products, alongside wealth, health, and protection solutions. The company was founded in 1848 and is headquartered in Central, Hong Kong, with its shares trading on the NYSE as an ADR under the ticker PUK.

Operating within the Life & Health Insurance sub-industry of the financials sector, Prudentials business model combines insurance underwriting with fee-based asset management, generating revenue from premiums and from the management of invested policyholder funds. Its focus on Asia and Africa targets markets characterized by low insurance penetration and growing middle-class demand for retirement, savings, and health coverage.

Headlines to Watch Out For
  • Asia life insurance premium growth drives new business value
  • Eastspring asset management AUM expansion boosts fee income
  • Hong Kong regulatory shifts reshape product distribution and margins
Piotroski VR-10 (Strict) 6.0
Net Income: 3.63b TTM > 0 and > 6% of Revenue
FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.31 > 1.0
NWC/Revenue: -547.5% < 20% (prev 55.97%; Δ -603.4% < -1%)
CFO/TA 0.01 > 3% & CFO 1.51b > Net Income 3.63b
Net Debt (340.0m) to EBITDA (4.40b): 0.08 < 3
Current Ratio: 0.06 > 1.5 & < 3
Outstanding Shares: last quarter (1.26b) vs 12m ago -7.91% < -2%
Gross Margin: 85.48% > 18% (prev 80.80%; Δ 4.68% > 0.5%)
Asset Turnover: 14.29% > 50% (prev 8.26%; Δ 6.03% > 0%)
Interest Coverage Ratio: 22.99 > 6 (EBIT TTM 4.40b / Interest Expense TTM 191.5m)
Altman Z'' -4.40
A: -0.74 (Total Current Assets 11.2b - Total Current Liabilities 177b) / Total Assets 224b
B: 0.06 (Retained Earnings 14.0b / Total Assets 224b)
C: 0.02 (EBIT TTM 4.40b / Avg Total Assets 211b)
D: 0.10 (Book Value of Equity 19.8b / Total Liabilities 203b)
Altman-Z'' = -4.40 = D
Beneish M -2.81
DSRI: 0.58 (Receivables 5.36b/4.99b, Revenue 30.2b/16.4b)
GMI: 0.95 (GM 80.80% / 85.48%)
AQI: 1.00 (AQ_t 0.95 / AQ_t-1 0.94)
SGI: 1.84 (Revenue 30.2b / 16.4b)
TATA: 0.01 (NI 3.63b - CFO 1.51b) / TA 224b)
Beneish M = -2.81 (Cap -4..+1) = A
What is the price of PUK shares?

As of September 05, 2026, the stock is trading at USD 27.75 with a total of 1,178,519 shares traded. Over the past week, the price has changed by +0.36%, over one month by -5.96%, over three months by +6.28% and over the past year by +6.97%.

Current recommended Stop Loss: 26.90 (which is 3.1% or 1.5 ATR below the current price).

Is PUK a buy, sell or hold?

Prudential has received a consensus analysts rating of 4.67. Therefore, it is recommended to buy PUK.

  • StrongBuy: 2
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the PUK price?
Analysts Target Price 37.5 35.2%
Prudential (PUK) - Fundamental Data Overview as of 05 September 2026
Market Cap USD = 34.9b (34.9b USD * 1.0 USD.USD)
P/E Trailing = 9.9824
P/E Forward = 9.4429
P/S = 2.4388
P/B = 1.6947
P/EG = 2.3598
Revenue TTM = 30.2b USD
EBIT TTM = 4.40b USD
EBITDA TTM = 4.40b USD
Long Term Debt = 4.46b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.51b USD (from shortTermDebt, last fiscal year)
Debt = 6.23b USD (from shortLongTermDebtTotal, last quarter) + Leases 310.0m
Net Debt = 340.0m USD (calculated: Debt 6.23b - CCE 5.89b)
Enterprise Value = 35.2b USD (34.9b + Debt 6.23b - CCE 5.89b)
Interest Coverage Ratio = 22.99 (Ebit TTM 4.40b / Interest Expense TTM 191.5m)
EV/FCF = 24.62x (Enterprise Value 35.2b / FCF TTM 1.43b)
FCF Yield = 4.06% (FCF TTM 1.43b / Enterprise Value 35.2b)
FCF Margin = 4.74% (FCF TTM 1.43b / Revenue TTM 30.2b)
Net Margin = 12.03% (Net Income TTM 3.63b / Revenue TTM 30.2b)
Gross Margin = 85.48% ((Revenue TTM 30.2b - Cost of Revenue TTM 4.39b) / Revenue TTM)
Gross Margin QoQ = 70.64% (prev none%)
Tobins Q-Ratio = 0.16 (Enterprise Value 35.2b / Total Assets 224b)
Interest Expense / Debt = 3.07% (Interest Expense 191.5m / Debt 6.23b)
Taxrate = 15.05% (662.5m / 4.40b)
NOPAT = 3.74b (EBIT 4.40b * (1 - 15.05%))
Current Ratio = 0.06 (Total Current Assets 11.2b / Total Current Liabilities 177b)
Debt / Equity = 0.31 (Debt 6.23b / totalStockholderEquity, last quarter 19.8b)
Debt / EBITDA = 0.08 (Net Debt 340.0m / EBITDA 4.40b)
Debt / FCF = 0.24 (Net Debt 340.0m / FCF TTM 1.43b)
Total Stockholder Equity = 18.9b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.72% (Net Income 3.63b / Total Assets 224b)
RoE = 19.25% (Net Income TTM 3.63b / Total Stockholder Equity 18.9b)
RoCE = 18.87% (EBIT 4.40b / Capital Employed (Equity 18.9b + L.T.Debt 4.46b))
RoIC = 7.95% (NOPAT 3.74b / Invested Capital 47.1b)
WACC = 7.61% (E(34.9b)/V(41.1b) * Re(8.50%) + D(6.23b)/V(41.1b) * Rd(3.07%) * (1-Tc(0.15)))
Discount Rate = 8.50% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -57.26 | Cagr: -29.08%
[DCF] Terminal Value 73.10% ; FCFF base≈1.61b ; Y1≈1.42b ; Y5≈1.14b
[DCF] Fair Price = 14.64 (EV 18.4b - Net Debt 340.0m = Equity 18.0b / Shares 1.23b; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 92.01 | Revenue CAGR: 81.71% | SUE: N/A | # QB: 0
EPS current Year (2025-12-31): EPS=1.95 | Chg30d=-4.11% | Revisions=-25% | GrowthEPS=+8.8% | GrowthRev=+6.6%
EPS next Year (2026-12-31): EPS=1.73 | Chg30d=-1.23% | Revisions=-25% | GrowthEPS=-14.5% | GrowthRev=+8.2%
[Analyst] Revisions Ratio: -40% (up=0, down=2)